Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB. Adams D, et al. Among authors: buades j. N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153. N Engl J Med. 2018. PMID: 29972753 Free article. Clinical Trial.
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.
Coelho T, Adams D, Conceição I, Waddington-Cruz M, Schmidt HH, Buades J, Campistol J, Berk JL, Polydefkis M, Wang JJ, Chen J, Sweetser MT, Gollob J, Suhr OB. Coelho T, et al. Among authors: buades j. Orphanet J Rare Dis. 2020 Jul 8;15(1):179. doi: 10.1186/s13023-020-01399-4. Orphanet J Rare Dis. 2020. PMID: 32641071 Free PMC article. Clinical Trial.
Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
Cisneros-Barroso E, Losada-López I, González-Moreno J, Buades J, Ferrer-Nadal A, Ripoll-Vera T, Usón M, Figuerola A, Montalà JC, Descals C, Salva-Ramonell F, Torres-Rovira J, Gene-Heym A, Fernández-Burgos I, Soler T. Cisneros-Barroso E, et al. Among authors: buades j. Amyloid. 2019;26(sup1):59-60. doi: 10.1080/13506129.2019.1582521. Amyloid. 2019. PMID: 31343326 No abstract available.
Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M, González-López E, Muñoz-Beamud F, Buades J, Galán L, Muñoz-Blanco JL, Sánchez-González J, Ibáñez B, Mirelis JG, García-Pavía P. Gallego-Delgado M, et al. Among authors: buades j. Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):923-930. doi: 10.1016/j.rec.2016.02.027. Epub 2016 Jun 10. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27291669 English, Spanish.
Significant reduction in proteinuria after treatment with tafamidis.
Ferrer-Nadal A, Ripoll T, Uson M, Figuerola A, Andreu H, Losada I, Gonzalez J, Cisneros-Barroso E, Buades J. Ferrer-Nadal A, et al. Among authors: buades j. Amyloid. 2019;26(sup1):67-68. doi: 10.1080/13506129.2019.1583186. Amyloid. 2019. PMID: 31343359 No abstract available.
51 results